Abnormal methylation status of FBXW10 and SMPD3, and associations with clinical characteristics in clear cell renal cell carcinoma

Wang,Jinyou; Li,Jian; Gu,Jun; Yu,Jian; Guo,Shicheng; Zhu,Yao; Ye,Dingwei

doi:10.3892/ol.2015.3707

Abnormal methylation status of FBXW10 and SMPD3, and associations with clinical characteristics in clear cell renal cell carcinoma

Authors:
- Jinyou Wang
- Jian Li
- Jun Gu
- Jian Yu
- Shicheng Guo
- Yao Zhu
- Dingwei Ye
View Affiliations

Affiliations: Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, P.R. China, State Key Laboratory of Genetic Engineering and Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Sciences, Fudan University, Shanghai 200433, P.R. China, State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200240, P.R. China
Published online on: September 16, 2015 https://doi.org/10.3892/ol.2015.3707
Pages: 3073-3080

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to evaluate the use of the 27K methylation array to investigate abnormal methylation of two genes and their associations with clinical characteristics in clear cell renal cell carcinoma (ccRCC). Six differentially‑methylated genes identified using the 27K methylation array were screened in the human RCC 786‑0 cell line and normal kidney tissues by bisulfite sequencing polymerase chain reaction (PCR). Differentially‑methylated regions (DMRs) that were abnormally hypermethylated in the cell line were further validated in renal tumor and paired normal tissues by pyrosequencing. The correlations between DMRs and differences (methylation rate of tumor minus that of paired normal tissue) according to gender, age, tumor size, Fuhrman grade and disease stage were assessed. Gene expression prior to and following 5‑Aza‑2'‑deoxycytidine treatment was examined using reverse transcription quantitative PCR (RT-qPCR). Two DMRs located in the FBXW10 and SMPD3 genes were found to be hypermethylated in the 786‑0 cells, but not in the normal kidney tissues. Pyrosequencing results showed that the average methylation rate of FBXW10 in the cancer tissues was significantly higher compared to that in the paired normal tissues (48.78 vs. 34.62%; P<0.001). The methylation rate of SMPD3 was also higher in the cancer tissues compared with the paired normal tissues (58.98 vs. 38.66%; P<0.001). In stage T1 RCC, the methylation rate of the tumor tissue was positively correlated with the Fuhrman grade (P=0.02). The difference in methylation between the tumor and normal tissues was significantly higher in the group with high Fuhrman grade for the two genes. Furthermore, the linear correlation between methylation difference and tumor size was also confirmed (P=0.01). The RT‑qPCR analysis demonstrated that SMPD3 and FBXW10 mRNA expression was significantly upregulated following 5‑Aza‑2'‑deoxycytidine treatment. The results identified two novel DMRs located in SMPD3 and FBXW10 that were hypermethylated in the ccRCC tissue samples. The methylation profile in ccRCC could potentially provide predictive information for clinical decisions.

View Figures

View References

1	Morrissey C, Martinez A, Zatyka M, et al: Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. Cancer Res. 61:7277–7281. 2001.PubMed/NCBI
2	Kawai Y, Sakano S, Suehiro Y, et al: Methylation level of the RASSF1A promoter is an independent prognostic factor for clear-cell renal cell carcinoma. Ann Oncol. 21:1612–1617. 2010. View Article : Google Scholar : PubMed/NCBI
3	Baylin SB and Jones PA: A decade of exploring the cancer epigenome-biological and translational implications. Nat Rev Cancer. 11:726–734. 2011. View Article : Google Scholar : PubMed/NCBI
4	Christensen BC, Houseman EA, Marsit CJ, et al: Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 5:e10006022009. View Article : Google Scholar : PubMed/NCBI
5	Gharizadeh B, Nordström T, Ahmadian A, et al: Long-read pyrosequencing using pure 2′-deoxyadenosine-5′-O'-(1-thiotriphosphate) Sp-isomer. Anal Biochem. 301:82–90. 2002. View Article : Google Scholar : PubMed/NCBI
6	Minardi D, Lucarini G, Filosa A, et al: Prognostic role of global DNA-methylation and histone acetylation in pT1a clear cell renal carcinoma in partial nephrectomy specimens. J Cell Mol Med. 13:2115–2121. 2009. View Article : Google Scholar : PubMed/NCBI
7	Houseman EA, Accomando WP, Koestler DC, et al: DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 13:862012. View Article : Google Scholar : PubMed/NCBI
8	Bibikova M, Le J, Barnes B, et al: Genome-wide DNA methylation profiling using Infinium® assay. Epigenomics. 1:177–200. 2009. View Article : Google Scholar : PubMed/NCBI
9	Dessau RB and Pipper CB: ‘R’-project for statistical computing. Ugeskr Laeger. 170:328–330. 2008.(In Danish). PubMed/NCBI
10	Zhao Y, Guo S, Sun J, et al: Methylcap-seq reveals novel DNA methylation markers for the diagnosis and recurrence prediction of bladder cancer in a Chinese population. PLoS One. 7:e351752012. View Article : Google Scholar : PubMed/NCBI
11	He Y, Cui Y, Wang W, et al: Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma. Neoplasia. 13:841–853. 2011. View Article : Google Scholar : PubMed/NCBI
12	Yu J, Zhu T, Wang Z, et al: A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. Clin Cancer Res. 13:7296–7304. 2007. View Article : Google Scholar : PubMed/NCBI
13	Chen YA, Choufani S, Ferreira JC, Grafodatskaya D, Butcher DT and Weksberg R: Sequence overlap between autosomal and sex-linked probes on the Illumina HumanMethylation27 microarray. Genomics. 97:214–222. 2011. View Article : Google Scholar : PubMed/NCBI
14	Braun R, Finney R, Yan C, et al: Discovery analysis of TCGA data reveals association between germline genotype and survival in ovarian cancer patients. PLoS One. 8:e550372013. View Article : Google Scholar : PubMed/NCBI
15	Jin J, Cardozo T, Lovering RC, Elledge SJ, Pagano M and Harper JW: Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev. 18:2573–2580. 2004. View Article : Google Scholar : PubMed/NCBI
16	Zhou ZY, Tu KS, Zhang J, et al: Expression of Fbxw7 and its correlation with cell proliferation in human hepatocellular carcinoma. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 28:1303–1306. 2012.(In Chinese). PubMed/NCBI
17	Clarke CJ, Guthrie JM and Hannun YA: Regulation of neutral sphingomyelinase-2 (nSMase2) by tumor necrosis factor-alpha involves protein kinase C-delta in lung epithelial cells. Mol Pharmacol. 74:1022–1032. 2008. View Article : Google Scholar : PubMed/NCBI
18	Demircan B, Dyer LM, Gerace M, Lobenhofer EK, Robertson KD and Brown KD: Comparative epigenomics of human and mouse mammary tumors. Genes Chromosomes Cancer. 48:83–97. 2009. View Article : Google Scholar : PubMed/NCBI
19	Shen Y, Takahashi M, Byun HM, et al: Boswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cells. Cancer Biol Ther. 13:542–552. 2012. View Article : Google Scholar : PubMed/NCBI
20	Chaturvedi P and Parnaik VK: Lamin A rod domain mutants target heterochromatin protein 1alpha and beta for proteasomal degradation by activation of F-box protein, FBXW10. PLoS One. 5:e106202010. View Article : Google Scholar : PubMed/NCBI
21	Tang Y, Liu C, Wang X, Liu D, Ingvarsson S and Chen H: Demethylation of the region around exon 2 of MLH1 gene in gastrointestinal cancer. Anticancer Res. 32:4861–4864. 2012.PubMed/NCBI
22	Godler DE, Slater HR, Bui QM, et al: FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles. J Mol Diagn. 13:528–536. 2011. View Article : Google Scholar : PubMed/NCBI
23	Smaldone MC and Uzzo RG: Active surveillance: a potential strategy for select patients with small renal masses. Future Oncol. 7:1133–1147. 2011. View Article : Google Scholar : PubMed/NCBI
24	Lane BR, Tobert CM and Riedinger CB: Growth kinetics and active surveillance for small renal masses. Curr Opin Urol. 22:353–359. 2012. View Article : Google Scholar : PubMed/NCBI
25	Mason RJ, Abdolell M, Trottier G, et al: Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance. Eur Urol. 59:863–867. 2011. View Article : Google Scholar : PubMed/NCBI